Priority Antiretrovirals for MPP November 2012 REW 2

First Page		Document Content
Date: 2012-11-30 11:05:09 Medicine Sexually transmitted diseases and infections Intellectual property law Monopoly Patent Antiretroviral drug Zidovudine Generic drug Didanosine Chemistry Purines Organic chemistry		Priority Antiretrovirals for MPP November 2012 REW 2 Add to Reading List Source URL: www.medicinespatentpool.org Download Document from Source Website File Size: 1,02 MB Share Document on Facebook

	Allowing Third-Party Use of Marks Without Risking Abandonment North Carolina Bar Association 2014 Intellectual Property Law Section Annual Meeting March 21, 2014 Pamela S. Chestek DocID: 1xTGy - View Document
	THE JOHN MARSHALL REVIEW OF INTELLECTUAL PROPERTY LAW REVIEW AND REFLECTION: COPYRIGHT HEARINGS AND RELATED DISCOURSE IN THE NATION’S CAPITAL MARIA A. PALLANTE DocID: 1vomA - View Document
	This Comment has been submitted by the UCI Intellectual Property, Arts, and Technology Clinic and Donaldson + Callif, LLP on behalf of Film Independent, the International Documentary Association, and Kartemquin Films. IT DocID: 1v5ti - View Document
	COMMENT OF THE GLOBAL ANTITRUST INSTITUTE, GEORGE MASON UNIVERSITY SCHOOL OF LAW, ON THE STATE ADMINISTRATION FOR INDUSTRY AND COMMERCE ANTI-MONOPOLY GUIDELINES ON THE ABUSE OF INTELLECTUAL PROPERTY RIGHTS January 11, 20 DocID: 1v37b - View Document
	Intellectual Property (Law 388) DocID: 1uCN9 - View Document